YOLFTbeta
Valerio Therapeutics

Valerio Therapeutics

ALVIO · PA · Healthcare / Biotechnology

0.4335EUR-0.02 (-4.30%)

Price History

Full chart

Market Stats

Previous Close0.453
Open0.466
Day Range0.43 – 0.466
52-Week Range0.057 – 0.98
Volume255.26K
Market Cap254.22M
P/E (TTM)0.00
Forward P/E6.46
EPS-0.02
Dividend Yield0.00%
Beta2.06
50-Day Avg0.6928
200-Day Avg0.3238

About

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody" drug conjugates, and chimeric antigen receptors. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Gilles Besin Ph.D.
  • Employees25
  • Headquarters49, boulevard du GEnEral Martial Valin, Paris, France, 75015, France
  • Websitehttps://valeriotx.com

Leadership

  • Dr. Gilles Besin Ph.D.CEO & Director
  • Mr. Wael Jdey Ph.D.CTO & Director

Financials

Income Statement

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-459.83K3.53M8.17M7.54M22.53M3.23M4.03M1.47M22.08M3.48M4.42M9.51M6.13M4.29M1.78M4.06M1.44M1.80M1.79M2.57M
Growth (%)--+667.52%+131.60%-7.80%+198.98%-85.66%+24.67%-63.59%+1405.44%-84.23%+27.05%+114.85%-35.54%-30.01%-58.58%+128.72%-64.48%+24.74%-0.39%+43.50%
Cost of Revenue79.83K143.13K52.30K314.14K398.75K859.07K9.55M375.23K264.27K248.85K337.00K655.00K634.00K215.00K350.00K1.94M368.00K514.00K533.00K513.00K847.00K
Gross Profit-79.83K316.71K3.48M7.86M7.14M21.67M-6.32M3.65M1.20M21.83M3.15M3.77M8.87M5.91M3.94M1.43M3.69M929.00K1.27M1.28M1.73M
Gross Margin-68.87%98.52%96.16%94.71%96.19%-195.57%90.68%81.98%98.87%90.32%85.19%93.33%96.49%91.84%80.46%90.94%64.38%70.39%71.39%67.08%
Operating Expense6.68M13.96M23.04M31.05M22.62M19.08M8.62M15.17M16.64M22.45M25.32M26.94M28.06M21.56M13.73M10.37M11.02M18.04M21.55M17.77M2.28M
Operating Income-6.75M-13.64M-19.56M-23.19M-15.48M2.59M-14.94M-11.52M-15.44M-616.07K-22.18M-23.17M-19.19M-15.64M-9.79M-8.94M-7.33M-17.11M-20.29M-16.49M-550.00K
Operating Margin--2965.95%-554.34%-283.74%-205.38%11.51%-462.36%-285.87%-1052.48%-2.79%-636.88%-523.69%-201.88%-255.33%-228.40%-503.27%-180.38%-1186.07%-1127.11%-919.63%-21.38%
EBITDA-6.64M-13.02M-18.05M-20.85M-14.76M3.33M-14.43M-10.85M-15.19M-1.34M-19.51M-19.79M-67.56M-946.00K-35.66M2.33M-5.86M-17.04M-18.44M-12.06M542.00K
EBITDA Margin--2832.46%-511.33%-255.02%-195.87%14.78%-446.58%-269.40%-1035.55%-6.06%-560.25%-447.22%-710.79%-15.44%-831.62%131.48%-144.19%-1180.67%-1024.67%-672.73%21.06%
Net Income-7.69M-13.17M-18.25M-21.37M-15.38M2.81M-14.62M-11.55M-15.32M-7.70M-19.41M-22.67M-59.07M-9.40M-33.73M1.09M-5.94M-19.56M-20.34M-23.93M-4.90M
Net Income Margin--2863.06%-517.06%-261.39%-204.12%12.47%-452.57%-286.68%-1044.53%-34.87%-557.41%-512.45%-621.47%-153.40%-786.57%61.32%-146.16%-1355.65%-1130.22%-1334.69%-190.36%
R&D-------4.25M9.98M9.61M12.68M14.07M15.36M4.93M5.84M4.00M4.90M11.05M9.68M5.14M578.00K
R&D as % of Total Revenue-------105.45%680.30%43.54%364.04%317.97%161.63%80.40%136.19%225.39%120.73%766.04%537.72%286.89%22.46%
Interest Expense-11.88K12.92K117.41K166.90K228.79K336.82K92.97K282.68K3.16M1.21M437.00K1.12M1.04M1.04M959.00K1.21M2.20M66.00K313.00K281.00K
Interest Expense % of Total Revenue-2.58%0.37%1.44%2.21%1.02%10.42%2.31%19.27%14.32%34.61%9.88%11.76%16.93%24.18%54.00%29.89%152.25%3.67%17.46%10.92%

Balance Sheet

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets33.24M22.71M63.54M42.37M21.34M26.33M34.08M22.12M17.74M152.00M129.24M125.10M78.07M63.25M37.63M46.51M53.06M43.09M35.27M17.93M15.23M
Total Liabilities3.68M3.74M17.05M15.15M8.57M7.48M11.18M10.38M10.31M30.03M26.44M31.01M28.20M17.85M20.43M17.47M20.12M20.82M20.47M26.19M13.16M
Total Equity29.56M18.97M46.49M27.22M12.76M18.85M22.90M11.74M7.44M121.97M102.80M94.09M49.87M45.40M17.20M29.04M32.94M22.27M14.80M-8.93M2.08M
Cash159.36K84.26K52.27K490.49K811.55K777.19K2.87M14.50M11.33M57.23M28.49M23.94M14.28M11.25M5.71M14.52M17.89M14.59M6.82M1.18M1.05M
Total Debt706.41K56.03K21.50K11.69K74.52K57.06K170.02K56.93K91.18K1.63M69.00K106.00K130.00K7.04M8.58M6.26M9.94M10.09M9.00M13.44M7.61M
Net Debt547.05K-28.24K-30.78K-478.80K-737.03K-720.13K-2.70M-14.45M-11.24M-55.60M-28.42M-23.84M-14.15M-4.21M2.87M-8.27M-3.12M-4.50M2.18M12.26M6.55M

Cash Flow

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.20M-12.17M-6.55M-27.71M-17.53M3.43M-11.68M-14.08M-14.09M-7.72M-23.12M-17.61M-28.28M-11.27M-7.70M-4.68M-8.57M-9.44M-18.60M-12.46M1.84M
Investing Cash Flow515.91K-89.24K-539.88K-1.85M-341.30K-326.63K-161.18K-63.04K-42.74K-328-235.00K1.85M-67.00K1.00K137.00K6.01M-66.00K-409.00K-177.00K-1.39M-1.16M
Financing Cash Flow33.83M723.62K45.77M5.00M890.47K3.14M19.56M-5.19K10.91M53.64M53.00K11.97M13.44M8.25M2.01M7.48M11.98M6.46M10.76M4.21M-774.00K
Capital Expenditure133.24K220.23K418.29K1.86M387.46K324.83K155.02K52.55K45.71K1.97K249.00K545.00K65.00K45.00K26.00K119.00K139.00K488.00K183.00K319.00K1.32M
Free Cash Flow-8.33M-12.39M-6.97M-29.57M-17.92M3.10M-11.84M-14.13M-14.14M-7.72M-23.36M-18.15M-28.35M-11.31M-7.72M-4.80M-8.71M-9.93M-18.78M-12.78M521.00K
Dividends Paid---------2.45M898.00K----------
FCF to OCF101.63%101.81%106.39%106.70%102.21%90.53%101.33%100.37%100.32%100.03%101.08%103.10%100.23%100.40%100.34%102.54%101.62%105.17%100.98%102.56%28.33%
Dividend Paid to FCF----------31.72%-3.84%----------

Earnings

Report DateFeb 26, 2014Aug 1, 2014Oct 25, 2016Apr 26, 2017Jul 28, 2017Mar 29, 2018May 16, 2018Jul 27, 2018Oct 25, 2018Mar 12, 2019Apr 17, 2019Jul 25, 2019Oct 24, 2019Apr 17, 2020Sep 17, 2020Oct 22, 2020Apr 21, 2021Jul 29, 2021Oct 29, 2021Apr 6, 2022Sep 13, 2022Nov 30, 2022Apr 24, 2023Jul 6, 2023Oct 27, 2023Mar 28, 2024Apr 30, 2024Oct 1, 2024Jul 28, 2025Oct 30, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00
EPS Actual0.000.000.000.00-0.23-0.930.00-0.170.00-0.010.00-0.150.00-0.380.060.00-0.03-0.050.00-0.01-0.100.00-0.180.000.000.000.00-0.07-0.090.00
Surprise------------------------------
Timing----------------------After-hoursAfter-hours--After-hours-After-hours-

Key Statistics & Ratios

Market Cap254.22M
Enterprise Value291.24M
Trailing P/E0.00
Forward P/E6.46
PEG Ratio2.53
Price / Sales98.80
Price / Book139.36
EPS-0.02
Book Value0.004
Revenue (TTM)2.57M
Gross Profit (TTM)1.73M
EBITDA3.45M
Profit Margin-190.36%
Operating Margin-25.62%
Return on Equity-731.84%
Return on Assets-2.07%
Shares Outstanding499.45M
Shares Float147.00M
Beta2.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 17, 2021766:761
  • Nov 24, 201465:62
  • Jul 2, 20133154:3153
  • Jul 4, 20111237:1193